Quantbot Technologies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Quantbot Technologies’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-130	Closed	-$1K	–	2218
2022 Q1	$1K	Hold	130	–	–	﹤0.01%	1587
2021 Q4	$4K	Buy	+130	New	+$5.26K	﹤0.01%	1398
2021 Q3	–	Sell	-130	Closed	-$7K	–	1998
2021 Q2	$7K	Buy	130 +90	+225%	+$5.33K	﹤0.01%	1342
2021 Q1	$2K	Buy	+40	New	+$4.16K	﹤0.01%	1339
2020 Q4	–	Sell	-20	Closed	-$1K	–	1759
2020 Q3	$1K	Buy	+20	New	+$2.27K	﹤0.01%	1249

Other funds holding SYRS

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Quantbot Technologies's SYRS Position: Q2 2022 in Review

Quantbot Technologies sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2022, closing a stake of 130 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in SYRS in Q3 2020 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 67 funds tracked by Wall St. Rank hold SYRS as of Q2 2022.

Quantbot Technologies reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 130 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1K.
Quantbot Technologies first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Quantbot Technologies's Syros Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q2 2021.
67 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.